Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning

Chagas disease, caused by the parasite Trypanosoma cruzi, affects millions of people in South America. The current treatments are limited, have severe side effects, and are only partially effective. Drug repositioning, defined as finding new indications for already approved drugs, has the potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Adasme, Melissa F., Bolz, Sarah Naomi, Adelmann, Lauren, Salentin, Sebastian, Haupt, V. Joachim, Moreno-Rodríguez, Adriana, Nogueda-Torres, Benjamín, Castillo-Campos, Verónica, Yepez-Mulia, Lilián, De Fuentes-Vicente, José A., Rivera, Gildardo, Schroeder, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699892/
https://www.ncbi.nlm.nih.gov/pubmed/33233837
http://dx.doi.org/10.3390/ijms21228809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699892/
https://www.ncbi.nlm.nih.gov/pubmed/33233837
http://dx.doi.org/10.3390/ijms21228809

Ejemplares similares